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Introduction
Opioid analgesics (OAs) are a type of prescription drugs, which are used to treat moderate to severe pain, particularly of visceral origin. Their mode of action is based on binding to opioid receptors, which are found principally in the central and peripheral nervous system and gastrointestinal tract.
They also find a significant application in heroin addiction treatment. On the other hand, all opioid analgesics themselves are well known for their addictive properties and therefore should be considered as potential drugs of abuse.
OAs comprise a number of structurally diverse chemical compounds, such as natural (e.g. morphine and codeine), semisynthetic morphine-like opioids (e.g. oxycodone, buprenorphine, ethylmorphin) and fully synthetic opioids (e.g. methadone, fentanyl, pentazocine, propoxyphene etc.). Tramadol, which was also included in this research, is structurally not an opioid, but does act as one by showing agonist activity at the μ-opioid receptor [1] .
The major sources of opioid compounds to the aquatic environment are human excretion and dumping of unused medications to the sewer. According to the available pharmacokinetic data [2] most of the OAs are extensively metabolized in the human body. Consequently, they are only partly excreted as unchanged drugs, while a significant percentage is excreted as metabolites [2] . For example, morphine is significantly metabolized after administration. Up to 87% of the dose is eliminated in urine with 75% present as morphine-3-glucuronide and only about 10% as unchanged morphine. In addition, several minor metabolites such as normorphine, morphine-6-glucuronide, diglucuronide, and sulphate conjugate are also formed. Codeine is biotransformed in man via Odemethylation to morphine and N-demethylation to norcodeine and excreted mainly in conjugated form. The metabolism of buprenorphine also leads to the number of products (primarily by Ndealkylation), which are excreted mainly as conjugated buprenorphine and norbuprenorphine. The metabolism of methadone is even more complex. The most important transformation is mono-and di-N-demethylation followed by spontaneous cyclisation to 2-ethylidene-1,5-dimethyl-3,3,diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3,-diphenylpyrrolidine (EMDP). The major urinary excretion products are methadone (5-50%) and EDDP (3-25%), while conjugated forms seem to be less important. The metabolic pattern of tramadol shows several major products. Approximately 29% of an oral dose is excreted as unchanged drug, 20% as free and conjugated O-desmethyltramadol, 17% as nortramadol and 20% as free and conjugated O-desmethylnortramadol. Since the main source of OAs in the environment are municipal wastewater effluents, the human pharmacokinetics data clearly show that their metabolic products should be taken into account when assessing their behavior and fate in the aquatic environment.
A C C E P T E D M A N U S C R I P T
There have been numerous reports in the literature which addressed the issue of environmental occurrence of opioid analgesics. The review by Verlicchi et al. [3] on the occurrence of various pharmaceuticals in urban wastewater showed that opioid analgesics, notably codeine and tramadol, were among the most abundant compounds. Moreover, codeine was highly ranked regarding potential environmental risk. The risk posed by OAs can be significantly enhanced in the watersheds influenced by discharges from pharmaceutical formulation facilities [4, 5] . Nevertheless, most of the literature published so far dealt only with a limited number of selected representatives of OAs, mainly as a part of broader scope studies, aimed to cover several therapeutic classes simultaneously [6] [7] [8] . Furthermore, OAs have been often included in the studies dealing with sewage epidemiology of illicit drugs [9] [10] [11] [12] [13] because they themselves have a significant record of abuse. Such studies focus primarily on influent wastewater and include only heroin-related metabolites (morphine, 6monoacetyl morphine and morphine glucuronide), codeine and methadone along with its main metabolite EDDP [9, 11] .
Most of the published analytical methods for the determination of OAs comprise a rather limited number of parent compounds and/or their human metabolites [14] [15] [16] [17] [18] [19] . The most comprehensive list of OAs was covered by a multiresidue LC-MS/MS method developed by Baker and Kasprzyk-Hordern [20] , who employed solid-phase extraction in combination with ultra-performace liquid chromatography-tandem mass spectrometry for wide scope multiclass assessment of 65 pharmaceuticals and illicit drugs, including simultaneous determination of twenty OAs and their metabolites. However, this method does not include some of the most polar representatives of OAderived compounds such as morphine derivatives dihydromorphine and hydromorphone and especially the two morphine glucuronides. Given the prominence of glucuronide conjugates in the human excreta [2] , their determination in wastewater might be very important for the correct assessment of the total concentration of OAs and thus for the comprehensive assessment of their behavior and fate in the aquatic environment. In order to achieve this goal, further improvement of analytical methodology is required, especially in terms of improved HPLC separation of polar OAs, which include some structurally related isobaric compounds.
The aim of this study was therefore to develop and validate a dedicated multiresidue LC-MS/MS method for simultaneous determination of 27 OAs, which should comprise both parent compounds and their major metabolites, including glucuronide conjugates, in environmental aqueous samples. A special emphasis was on improvement of chromatographic separation and sample cleanup for a more reliable determination of OAs in heavily loaded matrices. In order to improve the overall analytical reliability, stability of target compounds during sample preparation and storage was also systematically investigated. Finally, the method was applied for determination of opioid analgesics in
wastewater and river water samples from Croatia in order to assess their occurrence in the aquatic environment, in particular to demonstrate relative importance of so far neglected glucuronide conjugates.
Experimental

Chemicals and materials
The developed method included 27 analytes, involving both parent compounds and their human metabolites, and 19 deuterated analogues used as surrogate standards for quantitation ( Table 1) .
Additional information about structures, nomenclature and properties can be found in Table S1 in Supplementary material. Standard solutions of all target analytes and their deuterated analogues were purchased from Lipomed (Arlesheim, Switzerland) at concentration of 1 mg/mL and 0.1 mg/mL, respectively. Mixed standard solutions were prepared in MeOH at concentration of 10 µg/mL for analytes and 2 µg/mL for their deuterated analogues, and kept in the dark at -20 °C. LC-MS grade methanol and acetonitrile were delivered by BDH Prolabo (UK). Acetic and formic acid, also LC-MS grade, and phosphoric acid were purchased from Sigma-Aldrich (Germany).
Ethylenediaminetetraacetic acid disodium salt dihydrate (Na2EDTA * 2H2O) was also purchased from Sigma-Aldrich. 25% ammonia solution in water was supplied by Merck (Darmstadt, Germany).
Ultrapure water was obtained using an Elix-Milli-Q-system (Millipore, Bedford, USA). Solid-phase extraction cartridges, Oasis HLB (200 mg / 6 mL) and Oasis MCX (150 mg / 6 mL) were purchased from Waters (Milford, MA, USA), while Strata NH2 cartridges (200 mg / 3 mL) were purchased from Phenomenex (Torrance, California, USA). Whatman glass fiber filters (GF/D, 47 mm; pore size, 2.7 μm) were delivered by GE Healthcare (Maidstone, UK).
Sample collection and preparation
All wastewater samples for method optimization and validation, including raw wastewater (RW) and secondary effluent (SE) were collected at the central WWTP of the city of Zagreb, while wastewater samples for method evaluation were collected in Zagreb and Split. River water samples were collected along the Sava River in the city of Zagreb. All wastewater samples were 24 h-composite samples, while river samples were grab samples. Sample volumes for RW, SE and river water analyses were 125 mL, 250 mL and 500 mL, respectively. After the filtration through glass-fiber filters (GF/D), the mixture of surrogate standards (15 ng of each) was added to the samples. The enrichment of opioid analgesics from the filtered samples was performed using solid phase extraction (SPE). Two
types of SPE cartridges were tested during the method development: Oasis HLB and Oasis MCX. In the final procedure, samples were extracted by using Oasis MCX cartridges at pH 2. The pH was adjusted by addition of 85% phosphoric acid. The cartridges were previously preconditioned with 5 mL of MeOH, 5 mL of ultrapure H2O and 5 mL of 25 mM H3PO4 at the flow rate of approximately 5 mL/min. Before the elution, cartridges were washed with 6 mL of ultrapure water and subsequently dried under N2 (30 min). If the samples could not be analyzed on the same day, the cartridges containing adsorbed analytes were wrapped up in aluminum foil and stored at −20 °C until analysis.
The elution of the target opioids from the cartridge was performed using sequential elution. The first fraction was eluted with 6 mL of pure MeOH and this fraction, containing only interferences from wastewater matrix, was discarded. The second fraction, containing all target OAs, was eluted with 6 mL of 0.5% NH3 in MeOH. This purified extract was evaporated to dryness under N2 using a TurboVap evaporator (Caliper Life Science, Hopkinton, Massachusetts, USA). The residue was redissolved in 500 µL of H2O/MeOH (8:2, v/v) containing 50 mM ammonium acetate. precursor/product ion transitions were selected for each analyte and deuterated surrogate. First transition was used for quantification and second for additional confirmation. The collision energy and tube lens offset were optimized for each analyte and surrogate separately. The MRM parameters for all compounds are presented in Table 1 . Quantification of all analytes was performed using the corresponding deuterated internal standards.
LC-MS/MS analyses
Method validation
The method validation included determination of instrument detection limit (IDL), extraction recovery, matrix effect, accuracy, repeatability and method quantification limit (MQL) for each matrix (RW, SE, river water) in experiments performed in quadruplicate.
Linearity range was determined from 12-point internal standard calibration curves obtained by injecting standard solutions containing analytes in the concentration range from 0.5 to 1500 ng/mL and internal standards at the fixed concentration of 15 ng/mL. Linearity was verified by F-test, at 95% confidence level, according to IUPAC recommendations [21] . Sigma Plot was used for the statistical analysis. IDLs were determined by repetitive injection of low concentrations standard solution until signal to noise ratio was equal to 3. MQLs were determined as the minimum concentration of target analytes in standard solutions that can be measured and fulfilling the following criteria: bias from the calibration curve less than 25-30%, peak shapes acceptable, signal to noise ratio at least 8 and RSD of four replicates below 19%, taking into account method accuracy and sample volume for each sample matrix.
Extraction recovery was determined from the model experiment in which real water samples were spiked with target analytes either before (Abe) or after extraction (Aae). Samples were spiked at 1 µg/L, 500 ng/L and 50 ng/L for RW, SE and river water, respectively. Analytes already present in the original sample were also taken into account (Aorig). The extraction recovery was calculated by comparing the average responses of analyte spiked to samples after extraction to the samples spiked before extraction according to the following equation:
Extraction recovery (%) =
x 100
The method accuracy was assessed from model experiment in which samples were spiked both with analytes and internal standards. Samples were spiked with target compounds at 1 µg/L, 500 ng/L and 50 ng/L for RW, SE and river water, respectively, while the internal standards were added at 15 ng in In that experiment RW, SE and river water extracts were spiked at the concentration levels of 1 µg/L, 500 ng/L and 50 ng/L, respectively. Contributions of target analytes from the original sample (Aorig)
were also taken into account.
Stability experiments
Stability of target compounds during storage was studied for three scenarios: a) storage of water samples, b) storage of Oasis MCX cartridges after sample enrichment and c) storage of the final extracts.
Stability of opioid analgesics during water sample storage was tested as follows. Raw wastewater sample was filtered, spiked at concentration of 1 µg/L and then divided into five identical subsamples. One of these subsamples was processed immediately, including SPE, evaporation and LC-MS/MS analysis, according to the procedure described in Section 2.2-2.3 (above). Analyses in this experiment were conducted in triplicate. The remaining four subsamples were frozen and stored at -20 °C. These subsamples were processed and analyzed after being stored for 7, 30, 70 and 100 days. The results of the stability experiments were analyzed using SigmaPlot software.
Results and discussion
LC-MS/MS optimization
In order to achieve the best chromatographic separation of the selected opioid analgesics, four different reverse-phase HPLC columns were tested: Synergy POLAR-RP, YMCPro C18, Gemini C18 and ACE C18-PFP. YMCPro C18 and Gemini C18 are reverse phase columns, whose selectivity is mostly based on hydrophobic interactions, while the column ACE C18-PFP, which is also strongly hydrophobic, contains a specially developed ligand combining a C18 chain with integrated pentafluorophenyl functionality. This functionality provides additional π-π interactions as a basis for retention and separation of the target compounds. In contrast, Synergi Polar is a polar endcapped, ether-linked phenyl phase, which provides both polar and aromatic reversed-phase selectivity.
Different types of eluents were tested, including water, methanol and acetonitrile as solvents and addition of acetic or formic acid as modifiers. Acidic modifier was added to promote protonation of basic compounds and increase the MS signal. Formic acid addition (0.1%) to both eluents was selected in the optimized procedure. Regarding strong solvent, methanol provided slightly better performance than acetonitrile. Preliminary experiments showed that Gemini C18 column was suitable only for separation of the most lipophilic OAs, while the hydrophilic OAs (e.g. MOR, glucuronides, norMOR) were very poorly retained with very bad peak shapes ( Figure S1a, Supplementary info) , which is probably due to the relatively low carbon load of this column (14%). The alternative C18
column YMCPro with carbon load of 16% provided a much better separation of OAs ( Figure S1b ), however some of the isobaric compounds such as morphine and hydromorphone coeluted on this column, which precluded their reliable determination.
On the other hand, ACE C18-PFP column proved to be much more efficient and allowed satisfactory separation and good peak shapes for most of the target compounds ( Figure S1c) , except for the most polar analyte M3G. The best separation with satisfactory retention and peak shapes of polar
OAs was achieved with Synergi Polar column ( Figure 1 ) and therefore this column was selected for further method development. This separation is clearly superior to that shown by Baker and
Kaszprzyk [20] using a generic method based on BEH C18 column. Of 27 target analytes, there were only three co-eluting analyte pairs (DHCOD and OTRA, FNT and BUP and EDDP and PP). However, selectivity of the determination for the co-eluting compounds was fully assured by highly specific MRM detection, using the two most abundant precursor/product ion transitions for each analyte (see Table 1 ). The first transitions were used for quantification of analytes, while the second transitions were used as additional criteria for confirmation. M3G and M6G, which are structural isomers with identical product ions, were fully separated on the Synergi Polar column. MRM detection provided highly sensitive determination for most of the target OAs, however for some analytes, such as NOC, norBUP and PP, the sensitivity was relatively low (IDLs 5-15 pg). In order to improve sensitivity, for BUP and norBUP, several product ions were tested, which were previously used in literature [12, 17] and the transitions m/z 468 to m/z 396 and m/z 414 to m/z 187 were found to be the most sensitive for BUP and norBUP, respectively.
Optimisation of the extraction procedure
For the optimization of the extraction procedure, two types of SPE cartridges were compared, Oasis HLB and Oasis MCX, which have been widely used for the extraction of similar types of basic analytes [11, 12, 15, 20, 22] . Preliminary experiments, comparing three enrichment procedures described above, were performed using spring water spiked with target opioid analgesics and results are presented in Figure S2 (Supplementary material). Acceptable recoveries (57-115%) were achieved for all target analytes using each of the three procedures. The experiment showed that for some analytes, such as codeine and tramadol derivatives, better recoveries were obtained using HLB cartridges, especially at pH 10 (57-115%). In contrast, SFNT showed better recovery on MCX cartridge. Furthermore, this experiment demonstrated that most of the target compounds couldn't be completely desorbed from the HLB column using pure methanol and therefore an additional elution using 0.5% ammonia solution in methanol was required (not shown). The two eluates were analyzed separately and then added up to obtain the total concentrations. Based on these preliminary results, HLB enrichment at pH 10 seemed to be the most promising procedure.
However, this could not be verified in a more complex matrix such as wastewater. Firstly, the adjustment of pH to 10 in raw wastewater with ammonia solution resulted in the formation of a very fine calcium carbonate precipitate, which prevented percolation of the sample due to the cartridge clogging. To solve this problem, it was necessary to add high concentration of Na2EDTA (1 g/L) to wastewater samples before solid-phase extraction. The comparison of the three SPE protocols for the recovery of target compounds from raw wastewater is shown in Figure S3 . The recoveries using HLB cartridges were similar at pH 10 and pH 7.5, except for EDDP and TRA, whose recovery appeared to be much higher at natural pH (7.5). The recoveries of the lipophilic OAs using MCX cartridges were only slightly better from those obtained by HLB-based procedure, however for the polar OAs, such as morphine glucuronides, OM and HM, MCX showed a clearly superior performance. Morphine glucuronides were completely lost during the enrichment using HLB cartridges, indicating problems with their retention in complex real matrices.
Additional problem when using HLB cartridges was co-extraction of some matrix components, which caused a significant peak-shape deterioration (Figure 2A ). This problem could be rectified only after an additional clean up step using aminosilica cartridges as described earlier [23] ( Figure 2B ). This additional step could be skipped when using MCX cartridges for the enrichment (Figure 2C ), since this procedure applied sequential elution as described earlier [23, 24] . The predominant part of interfering compounds was eluted in the methanol fraction, before the final elution of the target analytes with 0.5% ammonia solution in methanol.
A C C E P T E D M
A N U S C R I P T
Method validation
Method validation parameters, including linearity, instrument detection limits, extraction recovery, matrix effect, repeatability and method quantification limits, were determined for three different matrices: raw wastewater, secondary effluent and river water, and the results are presented in Table   2 . For most of the analytes, linearity was attained in the range from 0.5 ng/mL to 500 ng/mL with few Very good extraction recoveries of OAs were achieved from all three water matrices for most of the target OAs (from 79% to 97% for RW, from 73% to 116% for SE and from 73% to 102% for river water). Somewhat lower recoveries in raw wastewater were obtained only for EDDP (44%) and TRA (63%). For EDDP, some losses were observed during the evaporation step in river water matrix.
Regarding matrix effects, the experiments showed relatively low effects in all examined matrices. For almost all analytes, matrix effects were below 20% with only few exceptions. A slightly more pronounced ion suppression (up to 38%) was observed in raw wastewater and river water for early eluting polar OAs (M3G, M6G and norMOR) but also for BUP and norBUP. On the other hand, a signal enhancement up to 27% was observed for some late eluting OAs (MTHD and SFNT) in the secondary effluent extracts. Low matrix effects were probably a result of sequential elution from MCX cartridges [23, 24] , employing elution with pure methanol (which removed a large percentage of matrix components) before the actual elution of the target OAs with basified methanol (0.5% NH3).
The losses during the sample preparation and matrix effects were successfully compensated using 19 surrogate standards. For those analytes for which isotopically labelled standards were not available (norMOR, M6G, DMOR, norCOD, OTRA, NOC, EMOR and NTRA) the surrogate standard was chosen based on the maximum similarity of the chemical structures and retention times. Another criterium was also the similarity of the extraction recoveries between the analyte and surrogate, determined in preliminary experiments. The morphine derivatives, norMOR and DMOR, were determined based on MOR-d3 as surrogate, however, this surrogate was not appropriate for the determination of EMOR.
Instead, a more closely eluting NFNT-d5 was found more suitable internal standard for EMOR.
Similarly, the two tramadol derivatives (OTRA and NTRA) were quantified using DCOD-d3 and NFNT-d5, respectively.
Careful selection of appropriate surrogate standards allowed determination of all target OAs with very good accuracies in all examined matrices (from 80% to 120%). Exceptions were somewhat lower accuracies for the determination of norBUP in secondary effluent (74%) and norCOD in river water
(75%) as well as for OTRA (126%). It should be stressed that for these compounds deuterated analogs were not available in this work.
The analytical repeatability of the target analytes was better than 11% for all matrices. The only exception was repetability of EDDP determination in raw wastewater (15%), which was probably related to lower recoveries of this compound (44%).
Overall, our analytical quality assurance parameters compare very well with the best literature achievements [20] , while providing analysis of an extended range of OAs.
Stability of opioid analgesics in samples
Stability of opioid analgesics in wastewater samples during sample storage and analysis is an essential part of accurate assessment of these compounds in real systems. Losses of target compounds during storage can lead to a significant underestimation of the true concentrations, while formation from co-occurring precursors would lead to an overestimation of the target compounds.
Among selected opioid compounds, both options are very likely [25] [26] [27] . When analyzing large number of samples collected in a sampling campaign, which cannot be processed on the same day, there are two strategies to minimize possible pitfalls due to the sample deterioration: immediate storage of the samples by freezing at low temperature (typically -20 °C) or extraction of the samples on the same day with options to store either adsorption cartridges or the final extract until instrumental analysis. In this work, stability of the target opioid analgesics was examined for raw wastewater, which is the most complex matrix regarding possible biotic and abiotic processes.
Determination of stability of OAs during wastewater sample storage at -20 °C showed that some analytes were stable even during prolonged storage time of 100 days with only slight changes in concentrations, which didn't exceed 20% (Table 3 ). On the other hand, for some analytes such as SFNT, PP, FNT, norBUP, NFNT, NTRA, EMOR, NOC, HM and NHC, a statistically significant decrease of concentrations (>25%) was observed already after 7 days. A gradual decrease for EMOR, NFNT and BUP continued during the prolonged storage of 100 days. The most unstable opioid compounds were morphine glucuronides and 6-AM, which is in accordance with our earlier observations [26] . The loss of glucuronides exceeded 50% after 30 days and the concentration continued to decrease till the end of experiment. It should also be noted that M3G was significantly less stable than M6G. Similarly, the concentration of 6-AM decreased by 86% on the day 100. It is interesting that decrease of M3G, M6G and 6-AM was accompanied by a significant increase in the concentration of MOR (up to 195% after 100 days). This shows that transformation between these analytes can occur during prolonged storage. 6-AM is an exclusive biomarker of heroin, so its stability in wastewater samples is essential
for a reliable estimation of heroin consumption using wastewater-based epidemiology approach. Our results show that estimation of heroin consumption based on 6-AM might be underestimated, if the samples were kept frozen before extraction. In addition, norBUP, also increased during the experiment, while its precursor BUP decreased.
Comparison of OAs stability on the MCX cartridges and in the SPE extracts stored at -20 °C after extraction of target compounds is presented in Figure 3 . Most of the opioid analgesics were found to be stable on MCX cartridges over a period of 30 days (loss <20%). A moderate, statistically significant decrease of the concentrations (up to 31%) was observed for norMOR, DMOR, MOR and HC. Only for M6G and EDDP a more pronounced concentration loss (up to 43%) was noticed, however the difference between the days 7 and 30 was not significant. A significant decrease in OA concentration in SPE extracts was observed for 6-AM (43%), EMOR (42%), DMOR (49%) and 6-morphine glucuronide (56%). Generally, opioid analgesics were more stable if the MCX cartridges were stored at -20 °C after SPE rather than SPE extracts. The stability of opioids during storage of SPE cartridges at -20 °C was also demonstrated by Baker and Kasprzyk-Hordern [25] , who reported that OAs, adsorbed onto MCX cartridges, were stable over a period of 6 weeks, and Gonzalez-Marino et al. [28] , who showed that OAs adsorbed onto HLB cartridges were stable for three months. Consequently, storage of MCX cartridges was selected as the best way to preserve the samples after extraction and to avoid sample alterations.
Method application
The developed method was applied for the analysis of target opioid analgesics in real samples, including raw water, secondary effluent and river water, collected in the area of the cities of Zagreb and Split (Croatia). The results are presented in Table 4 . The measured concentrations of individual opioids varied in wide ranges, from <MQL (low ng/L) to almost 1 µg/L. The most abundant opioid compounds were TRA and its metabolites NTRA and OTRA with the total concentration in WW exceeding 1 µg/L. It is interesting to note that TRA metabolites contributed significantly to the total concentration. This is in agreement with published literature [6, 7, 15] . Other relatively abundant opioid compounds found in untreated municipal wastewater included COD (237-625 ng/L), MOR (142-445 ng/L), M3G (4-370 ng/L), M6G (5-89 ng/L), MTHD (71-94 ng/L) and its metabolite EDDP (115-175 ng/L). Such results are not surprising since tramadol and codeine belong to the widely prescribed opioid analgesics for the treatment of moderate-severe pain in Europe [29] . On the other hand, MOR and its glucuronide conjugates originate mainly from the heroin abuse, while only a smaller part (10-15%) is associated with the therapeutic use [7, 30] . Although literature data often suggest that morphine glucuronides are quickly deconjugated by wastewater bacteria and biofilms A C C E P T E D M A N U S C R I P T [31] , our data from Split show that contribution of conjugated MOR can reach up to 50% of the total MOR concentration calculated on the molar basis. This indicated that the contribution of conjugated morphine must be taken into account when assessing the total morphine in municipal wastewater as a basis for the estimation of heroin consumption. Alternatively, heroin consumption can be estimated using 6-AM as exclusive heroin biomarker, and therefore, it is important to emphasize that the developed method allows its reliable measurement in low ng/L concentrations.
Moreover, in addition to its use as analgesic, the presence of MTHD and its metabolite EDDP can be related to extensive use of MTHD for the treatment of heroin addiction in Croatia. Other opioids, found in measurable concentrations, were norMOR, 6-AM and BUP, while most of the other semisynthetic OAs were not detected. It is interesting to note that the concentration of BUP (3-11 ng/L) was much lower than that of MTHD and EDDP, indicating that its use for the treatment of heroin addiction is less popular in Croatia.
It is interesting to note that the concentrations of OAs in secondary effluents were in the same range as those in raw wastewater, indicating that conventional biological wastewater treatment was rather inefficient in removing these compounds from wastewater. Lack of any removal was observed for TRA and its derivatives and methadone, while the removal efficiencies of COD and MOR were 21-28% and 65-67%, respectively. The elimination of minor opioids 6-AM and BUP were 50-67% and 20-43%, respectively. These findings are in a good agreement with our previously published data [11] and the recent literature [7, 20] . The only opioid which was efficiently eliminated in conventional WWTP was norMOR (>90%).
As could be expected, considering a relatively large dilution factor (typically >50), the concentrations of OAs in the Sava River were rather low (<MQL-72 ng/L) with prevalence of those compounds which were the most abundant opioid constituents in municipal wastewater (TRA, NTRA, OTRA, COD and EDDP). This could be primarily result of dilution since the results on removal efficiency in WWTP indicated that these compounds are rather refractory to biodegradation. The measured concentrations are lower than those reported by Baker and Kasprzyk-Hordern [20] , probably as a combined result of lower usage prevalence and a high dilution factor in the Sava River.
Conclusions
The developed analytical method allows reliable determination of 27 opioid analgesics and their metabolites at trace concentrations in different aqueous matrices thus providing a basis for their comprehensive study in the aquatic environment. Application of the method to real wastewater and
river water samples showed widespread occurrence of OAs in the aquatic environment. Inclusion of the number of OA metabolites along with their parent compounds indicated that the relative contribution of metabolites to the overall mass balance could be significant, which has often been neglected in literature. In particular, we showed that conjugated OAs may play an important role.
Results showed that opioid analgesics and their metabolites can reach significant levels in municipal wastewaters, raising concerns about their possible ecotoxic effects. The method is expected to be an important tool for systematic monitoring of OAs and assessment of their behavior and fate in the aquatic environment as well as for wastewater-based epidemiology to study their potential abuse.
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